GLOBAL LIVER INSTITUTE
Global Liver Institute (GLI) acknowledges the U.S. Food and Drug Administration’s (FDA) decision today to issue a Complete Response Letter (CRL) for the supplemental New Drug Application (sNDA) of obeticholic acid (OCA, OCALIVA®) for primary biliary cholangitis (PBC).
Members of Congress will return to Washington, DC, after the elections. Hopes remain for a productive November legislative session where some legislative priorities may finally make it to final passage.
In October, Global Liver Institute led its annual #OctoberIs4Livers campaign, focused on health equity and raising awareness about liver cancer.
Kristin Hatcher spent three days in Washington, D.C., at the NORD Breakthrough Summit to discuss equitable access to innovation.
In this issue, we explore recent findings that highlight the need for dietary changes, including the link between ultra-processed foods and metabolic disorders in children with obesity, as well as the benefits of increasing plain water intake can reduce mortality risk.
When my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective gallbladder surgery in 2017. During the surgery, my well-meaning surgeon found my liver to be nodular and decided to biopsy three separate spots while in the process of removing my gallbladder. What my surgeon did not know is how that biopsy would trigger a series of complications for my fragile liver.
Hepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you’re likely familiar with the chronic health challenges that accompany hepatitis C, especially in patients with multiple comorbidities.
Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the elections. Their staff are working hard to prepare for what many hope to be a productive November legislative session where some legislative priorities may finally make it to final passage.
Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers campaign. Read on for more information about the campaign and for updates on liver cancer care & prevention – especially for populations that face disparities in liver cancer care.
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.
Ipsen has achieved progress in the fight against cholestatic diseases, marking two important victories for patients.
Global Liver Institute (GLI) launches its seventh annual #OctoberIs4Livers campaign to raise awareness of and address disparities in liver cancer in recognition of Liver Cancer Awareness Month.
